Wellbutrin SRĀ®, a brand name of bupropion SR, is a sustained release version of bupropion, a norepinephrine and dopamine reuptake inhibitor (NDRI) used to treat major depressive disorder, including seasonal affective disorder (SAD).
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat my mood condition(s) | 30 |
|
|
2 | |||
| Depression | 20 |
|
|
|
5 | ||
| Major Depressive Disorder | 8 |
|
|
|
3 | ||
| Other | 5 |
|
1 | ||||
| low energy | 5 |
|
|
2 | |||
| Problems concentrating | 3 | 0 |
Mouse over the table for more information
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Other
|
5 | 36% |
|
|
Doctor's advice
|
4 | 29% |
|
|
Side effects too severe
|
3 | 21% |
|
|
Expense
|
3 | 21% |
|
|
Did not seem to work
|
2 | 14% |
|
|
Personal research
|
1 | 7% |
|
|
Course of treatment ended
|
1 | 7% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 23, 2009.